ArticleCancer science2010

Fc-engineered EGF-R antibodies mediate improved antibody-dependent cellular cytotoxicity (ADCC) against KRAS-mutated tumor cells.

Martin Schlaeth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.